China, Feb. 7 -- based Luye Pharma Group has entered into an agreement with South Korea's Myung In Pharm, granting the latter the exclusive rights to commercialise Rivastigmine Twice Weekly Transderma... Read More
Singapore, Feb. 7 -- Hear leaders at Resilience and AWS discuss how data and innovation are revolutionizing research and delivery of complex medicines. This discussion will cover how to: * Harness t... Read More